Cargando…

Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer

PURPOSE: This prospective longitudinal study quantifies health-related quality of life (HRQoL) up to 10 years following permanent iodine-125 ((125)I) prostate brachytherapy alone for localized prostate cancer. MATERIAL AND METHODS: In total, 120 patients completed a validated expanded prostate cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slevin, Finbar, Sethugavalar, Brinda, Al-Qaisieh, Bashar, Bownes, Peter, Mason, Joshua, Smith, Jonathan, Bottomley, David, Henry, Ann M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787209/ https://www.ncbi.nlm.nih.gov/pubmed/33437301 http://dx.doi.org/10.5114/jcb.2020.101686

Ejemplares similares

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020)

A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
por: Slevin, Finbar, et al.
Publicado: (2019)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2018)

Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
por: Zuber, Simon, et al.
Publicado: (2015)

A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
por: Peng, Sheng, et al.
Publicado: (2021)

Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
por: Mohan, Sukriti, et al.
Publicado: (2022)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022)

Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection
por: Salembier, Carl, et al.
Publicado: (2013)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Treasure of the Past IX: Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy
por: Loftus, T. P.
Publicado: (2001)

Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma
por: Gao, Yang, et al.
Publicado: (2017)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs
por: Kawata, Hidemichi, et al.
Publicado: (2012)

Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2014)

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Iodine-(125) plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion
por: Kaufman, Aaron R., et al.
Publicado: (2022)

Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
por: Nakiri, Makoto, et al.
Publicado: (2022)

Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer
por: Guinot, Jose Luis, et al.
Publicado: (2022)

Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed
por: Yamaguchi, Takahiro, et al.
Publicado: (2023)

(125)Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-up
por: Sekiguchi, Akane, et al.
Publicado: (2014)

A novel auto‐positioning method in Iodine‐125 seed brachytherapy driven by preoperative planning
por: Ma, Xiaodong, et al.
Publicado: (2019)

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
por: Yondorf, Menachem Z., et al.
Publicado: (2020)

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
por: Hadi, Indrawati, et al.
Publicado: (2021)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
por: Dong, Hong, et al.
Publicado: (2021)

Three-dimensional template combined with MR-guided iodine-125 brachytherapy for recurrent brain metastases
por: He, Xiangmeng, et al.
Publicado: (2023)

CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sbh5qeap22nl6u85cs2n0ucs0b